Investigating the Role of Antioxidants in Drug Development
American Journal Of Pharmacy And Pharmacology · 30.04.2024 · 5 (2) · 9-12
DOI: 10.71465/ajpp.3354 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal Of Pharmacy And Pharmacology, online erschienen am 30.04.2024. Verfasst von Dr. Emily Nova.
Abstract (Originalsprache)
Oxidative stress plays a significant role in the pathogenesis of many chronic and degenerative diseases. Antioxidants, which neutralize reactive oxygen species (ROS), have emerged as promising therapeutic agents in drug development. This article explores the role of antioxidants in the design of drugs for conditions such as cardiovascular diseases, neurodegenerative disorders, cancer, and aging-related ailments. It discusses natural and synthetic antioxidants, their mechanisms of action, recent advancements, challenges in clinical translation, and the future prospects of antioxidant-based drug development.
Zitieren
APA
Nova, D. E. (2024). Investigating the Role of Antioxidants in Drug Development. American Journal Of Pharmacy And Pharmacology, 5(2), 9-12. https://doi.org/10.71465/ajpp.3354
Vancouver
Nova DE. Investigating the Role of Antioxidants in Drug Development. American Journal Of Pharmacy And Pharmacology. 2024;5(2):9-12. doi:10.71465/ajpp.3354
BibTeX
@article{Nova2024,
author = {Nova, Dr. Emily},
title = {Investigating the Role of Antioxidants in Drug Development},
journal = {American Journal Of Pharmacy And Pharmacology},
year = {2024},
volume = {5},
number = {2},
pages = {9--12},
doi = {10.71465/ajpp.3354}
}
EUVIMED